EFFICACY AND SAFETY OF DABIGATRAN ETEXILATE VERSUS VITAMIN K ANTAGONIST FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN ROUTINE CLINICAL PRACTICE: RECOVERY DVT/PE PROSPECTIVE GLOBAL COHORT STUDY
2020
RE-COVERY DVT/PE is a multicenter, international, observational study of patients with deep vein thrombosis/pulmonary embolism (DVT/PE), comparing outcomes with dabigatran vs. vitamin K antagonists (VKAs).
The main outcomes were International Society on Thrombosis and Haemostasis major or
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI